Philadelphia chromosome-like acute lymphoblastic leukaemia (Ph-like or BCR::ABL1-like ALL)

What changed: Philadelphia chromosome-like acute lymphoblastic leukaemia (Ph-like or BCR::ABL1-like ALL)

Every dated change on the records linked to Philadelphia chromosome-like acute lymphoblastic leukaemia (Ph-like or BCR::ABL1-like ALL), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Milestone4This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordPhiladelphia chromosome-like acute lymphoblastic leukaemia (Ph-like or BCR::ABL1-like ALL)
Facts on this page last checked
When this page itself was last checked or edited.

2022 · 1

2022MilestonePhiladelphia chromosome-like acute lymphoblastic leukaemia (Ph-like or BCR::ABL1-like ALL)
WHO classifies B-ALL with BCR::ABL1-like features as an entity
A milestone in how this cancer is treated.

2016 · 1

2016MilestoneRuxolitinib
AALL1521 opens: ruxolitinib with chemotherapy for CRLF2 and JAK-pathway Ph-like ALL
A milestone in how this cancer is treated.

2014 · 1

2014MilestoneBCR::ABL1 (Philadelphia chromosome)
Sequencing shows kinase-activating lesions in nearly all Ph-like ALL, many drug-sensitive
A milestone in how this cancer is treated.

2009 · 1

2009MilestonePhiladelphia chromosome-like acute lymphoblastic leukaemia (Ph-like or BCR::ABL1-like ALL)
Ph-like (BCR-ABL1-like) ALL described by Dutch and US groups as a poor-prognosis subgroup
A milestone in how this cancer is treated.